Money Uber-Share Importable in red: About Due to Corona with less sales, loss reduced
India engages in Pandemic on Army Back
Day after Day India now reports about 350,000 corona new infections. The health system collapses. In the dramatic situation, the government strives for further support. © Amarjeet Kumar Singh / Zuma / Picture Alliance Light Name of Corona-Dead in a Crematorium in New Delhi The Corona infection numbers rise rapidly - One reason for this is the particularly contagious virus mutant B.1.617 , which in India was discovered.
The driving service provider over has submitted its quarterly balance sheet for a day after the competitor LYFT.
The Taxi Competitorcontinues to grow under the Corona crisis, but has significantly reduced its loss at the beginning of the year. In the three months to the end of March, a minus of $ 108 million (€ 90.0 million), as the company announced on Wednesday after US stock exchange. In the same period of the previous year, net loss had almost three billion dollars. However, the result benefited from a high special proceeds through the sale of Ubers robotic car division.
The main business with driving services continued to suffer from the pandemic, revenues decreased by 65 percent. An important support in the crisis remains the delivery division around the Esssbringdienst Ober Eat, which achieved a growth of 230 percent. Overall, Group-wide revenues fell by eleven percent to $ 2.9 billion. Uber boss Dara Khosrowshahi was satisfied despite the clear decline and stressed that the business has already recovered well.
The UCR share shows the Nasdaq 3.54 percent deeper at $ 49.37 in predatory trading.
editorial Finanzen.net / DPA-AFX
Why BionTech Founder Özlem doorCI against the easing of patent protection for vaccines has been proclaimed .
since US President Joe Biden, his government supported a patent release of the Corona vaccines, has started the debate internationally to travel. The French President Emmanuel Macron and the EU also signals its openness - but the Federal Government is rejects patent release for vaccines from . Özlem DoorCi, a mit greenery of the German vaccine pioneer Biontech, has also pronounced patent release in an interview with the US news channel CNN.